These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38951438)

  • 1. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.
    Cerezuela-Fuentes P; Gonzalez-Cao M; Puertolas T; Manzano JL; Maldonado C; Yelamos O; Berciano-Guerrero MA; Martin-Liberal J; Muñoz-Couselo E; Espinosa E; Drozdowskyj A; Berrocal A; Soria A; Marquez-Rodas I; Martin-Algarra S; Quindos M; Puig S;
    Clin Transl Oncol; 2024 Jul; ():. PubMed ID: 38951438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to melanoma drugs in Spain: a cross-sectional survey.
    Gonzalez-Cao M; Puertolas T; Manzano JL; Maldonado C; Yelamos O; Berciano-Guerrero MÁ; Cerezuela P; Martin-Liberal J; Muñoz-Couselo E; Espinosa E; Drozdowskyj A; Berrocal A; Soria A; Marquez-Rodas I; Martin-Algarra S; Quindos M; Puig S;
    Clin Transl Oncol; 2024 Oct; 26(10):2572-2583. PubMed ID: 38750345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
    Sánchez-Díaz M; Flórez Á; Ara-Martín M; Arias-Santiago S; Botella-Estrada R; Cañueto J; Carretero-Hernández G; Coto-Segura P; de Eusebio-Murillo E; García-Latasa de Araníbar FJ; García-Patos Briones V; Gardeazabal García J; Gómez-Fernández C; Hernández-Ostiz S; Izu Belloso R; López-Ávila A; Manchado López P; Martín-Santiago A; Martinez de Espronceda Ezquerro I; Mateu-Puchades A; Mercader-García P; Notario Rosa J; Palacio Aller L; Pérez-Hortet C; Quintana-Castanedo L; Rivera R; Rocamora Duran V; Rodríguez-Nevado IM; Ruiz-Villaverde R; Suárez J; Trasobares-Marugán L; Vizán-de Uña C; Yanguas I; Zulaica-Garate A; García-Doval I; Descalzo MÁ; Grau-Pérez M; Carrascosa-Carrillo JM
    Actas Dermosifiliogr; 2024 Mar; 115(3):237-245. PubMed ID: 37890617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
    Sánchez-Díaz M; Flórez Á; Ara-Martín M; Arias-Santiago S; Botella-Estrada R; Cañueto J; Carretero-Hernández G; Coto-Segura P; de Eusebio-Murillo E; García-Latasa de Araníbar FJ; García-Patos Briones V; Gardeazabal García J; Gómez-Fernández C; Hernández-Ostiz S; Izu Belloso R; López-Ávila A; Manchado López P; Martín-Santiago A; Martinez de Espronceda Ezquerro I; Mateu-Puchades A; Mercader-García P; Notario Rosa J; Palacio Aller L; Pérez-Hortet C; Quintana-Castanedo L; Rivera R; Rocamora Duran V; Rodríguez-Nevado IM; Ruiz-Villaverde R; Suárez J; Trasobares-Marugán L; Vizán-de Uña C; Yanguas I; Zulaica-Garate A; García-Doval I; Descalzo MÁ; Grau-Pérez M; Carrascosa-Carrillo JM
    Actas Dermosifiliogr; 2024 Mar; 115(3):T237-T245. PubMed ID: 38242435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain.
    Rodríguez-Lescure A; de la Peña FA; Aranda E; Calvo A; Felip E; Garrido P; Vera R
    Clin Transl Oncol; 2020 Dec; 22(12):2253-2263. PubMed ID: 32533318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of communication systems of suspected occupational disease in the Autonomous Communities, Spain].
    García Gómez M; Urbaneja Arrúe F; García López V; Estaban Buedo V; Rodríguez Suárez V; Miralles Martínez-Portillo L; González García I; Egea Garcia J; Corraliza Infanzon E; Ramírez Salvador L; Briz Blázquez S; Armengol Rosell R; Cisnal Gredilla JM; Correa Rodríguez JF; Coto Fernández JC; Díaz Peral MR; Elvira Espinosa M; Fernández Fernández I; García-Ramos Alonso E; Martínez Arguisuelas N; Rivas Pérez AI
    Rev Esp Salud Publica; 2017 Mar; 91():. PubMed ID: 28301455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
    Wang JL; Yin WJ; Zhou LY; Zhou G; Liu K; Hu C; Zuo XC; Wang YF
    Clin Rheumatol; 2020 Mar; 39(3):769-778. PubMed ID: 31823140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
    Kandolf Sekulovic L; Guo J; Agarwala S; Hauschild A; McArthur G; Cinat G; Wainstein A; Caglevic C; Lorigan P; Gogas H; Alvarez M; Duncombe R; Lebbe C; Peris K; Rutkowski P; Stratigos A; Forsea AM; De La Cruz Merino L; Kukushkina M; Dummer R; Hoeller C; Gorry C; Bastholt L; Herceg D; Neyns B; Vieira R; Arenberger P; Bylaite-Bucinskiene M; Babovic N; Banjin M; Putnik K; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Ymeri A; Stojkovski I; Garbe C
    Eur J Cancer; 2018 Nov; 104():201-209. PubMed ID: 30388700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for Non-melanoma Skin Cancer.
    Shalhout SZ; Emerick KS; Kaufman HL; Miller DM
    Curr Oncol Rep; 2021 Aug; 23(11):125. PubMed ID: 34448958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
    Salvador J; Aparicio J; Baron FJ; Garcia-Campelo R; Garcia-Carbonero R; Lianes P; Llombart A; Isla D; Piera JM; Munoz M; Puente J; Rivera F; Rodriguez CA; Virizuela JA; Martin M; Garrido P
    Clin Transl Oncol; 2017 Mar; 19(3):341-356. PubMed ID: 27562312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic evaluation of non-melanoma skin cancer and actinic keratosis.
    Higashi MK; Veenstra DL; Langley PC
    Pharmacoeconomics; 2004; 22(2):83-94. PubMed ID: 14731050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers.
    Zeng Q; Chen C; Chen D; Zhang G; Wang X
    Curr Treat Options Oncol; 2023 Dec; 24(12):1978-1993. PubMed ID: 38095778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative epidemiological study of non-melanoma skin cancer between Spanish and north and central European residents on the Costa del Sol.
    Aguilar Bernier M; Rivas Ruiz F; De Troya Martín M; Blázquez Sánchez N
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):41-7. PubMed ID: 21366710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer.
    Tanese K; Nakamura Y; Hirai I; Funakoshi T
    Front Med (Lausanne); 2019; 6():160. PubMed ID: 31355203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study.
    Rubió-Casadevall J; Hernandez-Pujol AM; Ferreira-Santos MC; Morey-Esteve G; Vilardell L; Osca-Gelis G; Vilar-Coromina N; Marcos-Gragera R
    Cancer Epidemiol; 2016 Dec; 45():6-10. PubMed ID: 27639035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on Spain's legislative experience providing access to healthcare to irregular migrants: a qualitative interview study.
    Hsia RY; Gil-González D
    BMJ Open; 2021 Aug; 11(8):e050204. PubMed ID: 34446496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors.
    Hooiveld-Noeken JS; Eggen AC; Rácz E; de Vries EGE; Reyners AKL; Jalving M
    Crit Rev Oncol Hematol; 2022 Dec; 180():103855. PubMed ID: 36257534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis.
    Tejera-Vaquerizo A; Descalzo-Gallego MA; Otero-Rivas MM; Posada-García C; Rodríguez-Pazos L; Pastushenko I; Marcos-Gragera R; García-Doval I
    Actas Dermosifiliogr; 2016 May; 107(4):318-28. PubMed ID: 26852370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazole.
    Jeck J; Wingen-Heimann SM; Thielscher C; Kron A; Bonn J; Jakobs F; Grau S; Enoch DA; Micallef C; Cornely OA; Kron F
    Mycoses; 2021 Oct; 64(10):1213-1222. PubMed ID: 34134179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.